Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-11-24Clinical Trial Update: Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases [Phase 2]
A Phase 2 clinical trial evaluating Sm-EDTMP with autologous peripheral blood stem cell transplantation in breast cancer patients with bone-…
-
CLINICAL_TRIALS trial_result · 2015-11-24Clinical Trial Update: Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancer [Phase 3]
This Phase 3 trial completed a comparative analysis of neoadjuvant chemotherapy regimens for breast cancer. The provided snippet does not in…
-
CLINICAL_TRIALS trial_result · 2015-11-24Clinical Trial Update: Sienna+® Injection Time Study 4 Arms [Phase 4]
A Phase 4 clinical trial update for Sienna+ Injection Time Study with four arms in breast cancer, with the trial status currently listed as …
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Open-label Study of STA-9090 for Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 open-label study of ganetespib (STA-9090) in metastatic breast cancer completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Comparison of PEM Uptake Value (PUV) and Standardized Uptake Value (SUV) in Patients With Malignancies of the Breast
This clinical trial update compares PEM Uptake Value (PUV) with Standardized Uptake Value (SUV) in patients with breast cancer to assess ima…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Older [Phase 2]
Phase 2 trial evaluating immune responses to pneumococcal and influenza vaccines in adults 65 and older with breast, lung, or prostate cance…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: The Impact of Physical Activity on the Outcome of Surgery
A completed clinical trial from Sahlgrenska University Hospital examines how physical activity influences postoperative outcomes in patients…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Upper Extremity Lymphatic Mapping for Breast Cancer Patients [NA]
A completed clinical trial from Memorial Sloan Kettering Cancer Center evaluated upper extremity lymphatic mapping in breast cancer patients…
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer [Phase 3]
Phase 3 trial evaluating megestrol acetate (Megace) for treating hot flashes in patients after breast cancer treatment has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: Selective Image Guided Resection of Axillary Lymph Nodes [NA]
A clinical trial evaluating selective image-guided resection of axillary lymph nodes in breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer [Phase 3]
Phase 3 trial assessing radiation therapy for bone metastases in breast and prostate cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-16Clinical Trial Update: Quality of Life in African-American or Caucasian Female Breast Cancer Survivors
A completed clinical trial assessing quality of life among African-American or Caucasian female breast cancer survivors has been reported, f…
-
CLINICAL_TRIALS trial_result · 2015-11-11Clinical Trial Update: Capecitabine in Women With Operable Breast Cancer [Phase 2]
A Phase 2 trial of capecitabine in women with operable breast cancer has been terminated, with limited details provided in the update.
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy [Phase 3]
A Phase 3 clinical trial assessing the effects of denosumab in breast cancer patients receiving aromatase inhibitor therapy has completed wi…
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. [NA]
Continuation study of sunitinib malate for patients who left a prior sunitinib trial; completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-06Clinical Trial Update: EMG at Performing ULTN 1 in Breast Cancer Patients [NA]
Clinical trial record notes the completed status of a study evaluating electromyography (EMG) in a physiotherapy-related context for breast …
-
CLINICAL_TRIALS trial_result · 2015-11-05Clinical Trial Update: An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer [Phase 2]
Open-label Phase 2 window-of-opportunity study evaluating ganetespib in women with breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-05Clinical Trial Update: Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer [Phase 1, Phase 2]
This clinical trial update reports results from a Phase I/II study of vorinostat with paclitaxel and bevacizumab in metastatic breast cancer…
-
CLINICAL_TRIALS trial_result · 2015-11-05Clinical Trial Update: Clinical Value of 89Zr-trastuzumab PET [Phase 2]
Phase 2 clinical trial evaluating the clinical value of 89Zr-trastuzumab PET imaging in metastatic breast cancer; study completed.
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: Treatment With Ribavirin for Patients With Metastatic Breast Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating ribavirin for metastatic breast cancer was terminated, with no published results reported.
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: Clinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin in Patients With Solid Tumors and Her2 Positive Metastatic Breast Cancer That Have Previously Failed Herceptin [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluated the combination of trastuzumab (Herceptin) and tanespimycin in patients with solid tumors and HER2-pos…
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: Clinical Trial of Intravenous Alvespimycin in Patients With Her2 Positive Breast Cancer [Phase 2]
A Phase 2 trial evaluating intravenous Alvespimycin in HER2-positive breast cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2015-10-30Clinical Trial Update: Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer [Phase 1, Phase 2]
Terminated Phase 1b/2 study of buparlisib (BKM120) in combination with trastuzumab for HER2-positive metastatic breast cancer, with results …
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer Patients [Phase 2]
Phase 2 trial evaluating AMG 386 (trebananib) with paclitaxel, with or without bevacizumab, as first-line therapy for HER2-negative breast c…
-
CLINICAL_TRIALS trial_result · 2015-10-27Clinical Trial Update: A Study Inhibiting Telomerase to Reverse Trastuzumab Resistance in HER2+ Breast Cancer [Phase 1]
Phase 1 study evaluating a telomerase inhibitor to reverse trastuzumab resistance in HER2-positive breast cancer has completed.